NEW YORK, Jan. 19, 2024 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of Eagle Pharmaceuticals, Inc. Shareholders who purchased shares of EGRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….